| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 03/25/2008 | US7348318 α-Amino-N-(diaminophosphinyl)lactam derivatives |
| 03/25/2008 | US7348315 Methods of treating heart failure with modified ATP, ADP and AMP compounds |
| 03/25/2008 | US7348173 Fatty-acid amide hydrolase |
| 03/25/2008 | CA2268709C Hiv protease inhibitors |
| 03/20/2008 | WO2008033572A1 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 03/20/2008 | WO2008032531A1 Process for production of optically active phosphorous compound |
| 03/20/2008 | WO2008031743A1 Heterocyclic bridged biphenyls and their use in oleds |
| 03/20/2008 | WO2008031333A1 The prepartion and the use of ethoxy combretastatins and their prodrugs |
| 03/20/2008 | WO2008031199A1 Ionic compounds having bronsted acidity and uses thereof |
| 03/20/2008 | WO2008019090A3 Agonists of the sphingosine-1-phosphate receptor |
| 03/20/2008 | WO2008016692A3 Chemical compounds |
| 03/20/2008 | WO2007147163A3 Compositions comprising carotenoid analogs or derivatives and methods for synthesis |
| 03/20/2008 | US20080071121 Hydrogenation of esters with ru/bidentate ligands complexes |
| 03/20/2008 | US20080071116 Anticancer drugs |
| 03/20/2008 | US20080071115 Reduction of dichlorophenylphosphane in presence of hydrogenation catalyst using hydrogen;cyclization; using tertiary amine and solvent; reacting with acid halide in presence of a base |
| 03/20/2008 | US20080071112 Process for the Manufacture of Aminoalkylenephosphonic Acid Compounds in the Presence of a Heterogeneous Catalyst |
| 03/20/2008 | US20080071104 Antiagglomerants; storage stability; compaction pellets; efficient materials handling; blending with silica anticaking agent |
| 03/20/2008 | US20080071102 Processes for preparing niobium alkoxides, and niobium alkoxides prepared thereby |
| 03/20/2008 | US20080071098 Hydrogenation of esters with ru/tetradentate ligands complexes |
| 03/20/2008 | US20080071072 Aqueous solution containing cationic stabilizer; plasmids; genomes; kits |
| 03/20/2008 | US20080070871 N-Phenylphosphoric Acid Triamides, Method for the Production Thereof and Their Use as Agents for Regulating or Inhibiting Enzymatic Urea Hydrolysis |
| 03/20/2008 | US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 03/20/2008 | US20080070868 Novel Thiazole Inhibitors of Fructose 1,6-bisphosphatase |
| 03/20/2008 | US20080070867 2-Imidazolone and 2-Imidazolidinone Heterocyclic Inhibitors of Tyrosine Phosphatases |
| 03/20/2008 | US20080070866 Immunosuppressants for autoimmune diseases such as multiple sclerosis, transplant rejection; sphingosine-1-phosphate (S1P) receptor agonists; (S)-2-Amino-2-(5-(4-(2-(pentyloxy)ethoxy)-3-(trifluoromethyl)phenyl)-1,3,4-thiadiazol-2-yl)propyl dihydrogen phosphate for example |
| 03/20/2008 | US20080067504 Organic thin film transistor comprising phosphate-based self-assembled monolayer and method of manufacturing the same |
| 03/20/2008 | DE10291037B4 Verfahren zur Herstellung von Tantal- und Niobalkoholaten A process for producing tantalum and Niobalkoholaten |
| 03/20/2008 | CA2662737A1 The preparation and the use of ethoxy combretastatins and their prodrugs |
| 03/19/2008 | EP1900717A2 Method for manufacturing extremely pure niobium alkoxides |
| 03/19/2008 | EP1899358A2 Novel p-chiral functionalised arylphosphines and derivatives, the preparation and use thereof for asymmetrical catalysis |
| 03/19/2008 | EP1899289A1 Method for producing aryl amines, aryl ethers and aryl thioethers |
| 03/19/2008 | EP1898722A2 Polar lipid mixtures, their preparation and uses |
| 03/19/2008 | EP1608704B1 Thiophosphine compounds and method of making polymerisable compositions containing them and their use for making ophtalmic lenses |
| 03/19/2008 | CN101146618A Unsymmetrically substituted phospholane catalysts |
| 03/19/2008 | CN101146575A New class of gamma delta T cells activators and use thereof |
| 03/19/2008 | CN101143880A Phosphine isocoumarin salt and preparation method thereof |
| 03/19/2008 | CN101143879A Sulfur-containing ring-free nucleosides phosphonate analogue and preparation method thereof |
| 03/19/2008 | CN101143878A Method for preparing tetrakis(hydroxymethyl)phosphonium chloride from phosphine generated in sodium hypophosphite production |
| 03/19/2008 | CN101143877A Method for preparing tetrakis(hydroxymethyl)phosphonium sulfate from phosphine generated in sodium hypophosphite production |
| 03/19/2008 | CN101143876A Method for preparing melamine phosphate (borate) fire retardant |
| 03/19/2008 | CN101143813A Treatment method for waste water of acephate producing process |
| 03/19/2008 | CN101143804A Method for manufacturing extremely pure niobium alkoxides |
| 03/19/2008 | CN101143752A Amino trimethylene phosphonic salt with content more than 90% and preparation technique thereof |
| 03/19/2008 | CN100375748C Substituted phenoxy-acetoxy-aromatic heterocyclic radical-alkyl ester phisphinic acid possessing bactericidal and herbicidal activity, and preparation thereof |
| 03/19/2008 | CN100375747C Method for the production of monohydro-perfluoroalkanes, bis(perfluoroalkyl)phosphinates, and perfluoroalkylphosphonates |
| 03/18/2008 | US7345186 Oxathiazaphospholidine free radical control agent |
| 03/18/2008 | US7345185 Method for producing organoacylphosphites |
| 03/18/2008 | US7345179 Reacting 2-hydroxymethyl-n-protected-4-substituted pyrrolidine with arylsulfonyl chloride or an optionally substituted alkylsulfonyl chloride in the presence of a base; reacting with p-hydroxybenzenecarboxylic acid derivative (ethyl 4-(N-benzyloxycarbonyl-(4S)-methoxy-(2S)-pyrrolidinylmethoxy)benzoate) |
| 03/18/2008 | US7345174 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide |
| 03/18/2008 | US7345091 Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
| 03/18/2008 | US7345082 Phosphinic acids |
| 03/18/2008 | US7345033 Carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them |
| 03/18/2008 | US7345032 alkylation of 1,3-diaminopropane or addition to diethyl vinylphosphonate, to form N-(3-aminopropyl)aminoethanephosphonic acid diethyl ester, which is condensed with a squarate compound to give drugs used as N-methyl-D-aspartic acid (NMDA) antagonists |
| 03/18/2008 | US7344895 Production and use of in situ-modified nanoparticles |
| 03/18/2008 | US7344701 For conjugation with biomolecules, drugs, and toxins |
| 03/18/2008 | CA2429378C Improved process for water soluble azole compounds |
| 03/18/2008 | CA2380326C Novel 2-decarboxy-2-phosphinico prostaglandin f analogs |
| 03/18/2008 | CA2321712C Tridentate ligand-containing metal catalyst complexes for olefin polymerization |
| 03/18/2008 | CA2238365C Water soluble tri-substituted 1,2-dioxetane compounds having increased storage stability, synthetic processes and intermediates |
| 03/18/2008 | CA2206125C N-substituted hydrazinophenylsulphonylureas, as herbicides and plant growth regulators |
| 03/13/2008 | WO2008030843A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity |
| 03/13/2008 | WO2008030112A1 Processes of preparing asymmetric dinitrobenzamide mustard compounds, intermediate compounds useful therein and products obtained therefrom |
| 03/13/2008 | WO2008029754A1 Process for production of optically active aminophosphinylbutanoic acid |
| 03/13/2008 | WO2008029744A1 Diamine compound having phosphorylcholine group, polymer thereof and method for producing the same |
| 03/13/2008 | WO2008028858A1 Liquid polymeric phosphites and phosphonites as stabilizers |
| 03/13/2008 | WO2008008718A3 Cyclopentane derivatives as antiglaucoma agents |
| 03/13/2008 | WO2008002886A3 Phosphonium salts for polymer composites and their preparation |
| 03/13/2008 | US20080064893 Emissive monomeric metal complexes |
| 03/13/2008 | US20080064889 Countercurrent liquid/liquid extraction; multistep vacuum distillation; solvent recycling |
| 03/13/2008 | US20080064838 Such as (3-(2-pyridyl-1-methylethyl)indenyl)chromium dichloride for catalytic addition polymerization |
| 03/13/2008 | US20080064704 1,4-Diaryl-Dihydropyrimidin-2-Ones and Their Use as Human Neutrophil Elastase Inhibitors |
| 03/13/2008 | US20080064662 Agonists having a biphenyl moiety in combination with an amide linkage at the core of the structure enhances selectivity for S1P1 receptor without causing hypotension or bradycardia; transplant rejection, autoimmune diseases; 2-Amino-N-[4-(biphenyl-4-yloxy)-phenyl]3-hydroxy-2-methyl-propionamide |
| 03/13/2008 | US20080064661 Dihydroxyl compounds and compositions for cholesterol management and related uses |
| 03/13/2008 | US20080064645 A carbohydrate linked to a fluorophore through a 2-amido-2-(1-hydroxyalkyl)ethoxy linkage; inhibition of caveolar endocytosis, plasma membrane microdomain formation, virus binding and infection, transmembrane signaling, and integrin function in cells; anticarcinogenic and antiinflammatory agents |
| 03/13/2008 | US20080064606 Selectively binds with absolute control over orientation and density without requiring prior synthetic modification or purification to make a stable protein chip; rapid and irreversible; assaying kinase or protease activity |
| 03/13/2008 | US20080063683 hydroxyapatite material is formed by hydrothermal conversion heating, purifiying the sample followed by hydrothermal conversion steps and treating with a divalent metal phosphate solution; bone grafts; high strength; bioactivity |
| 03/13/2008 | CA2662852A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity |
| 03/13/2008 | CA2662624A1 Fluorescent cell markers |
| 03/13/2008 | CA2662391A1 Process for production of optically active aminophosphinylbutanoic acids |
| 03/13/2008 | CA2662035A1 Liquid polymeric phosphites and phosphonites as stabilizers |
| 03/12/2008 | EP1896489A1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof |
| 03/12/2008 | EP1896428A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders |
| 03/12/2008 | EP1896135A2 Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids |
| 03/12/2008 | EP1896040A2 Phosphoramidate alkylator prodrugs |
| 03/12/2008 | EP1554293B1 Bis-chelating ligand and use thereof in carbonylation processes |
| 03/12/2008 | CN101142162A Process for the preparation of a dicarboxylic acid |
| 03/12/2008 | CN101139363A M-crystal system of adefovir dipivoxil ester and preparation method and medicine application |
| 03/12/2008 | CN101139362A Continuous crystallization method for glyphosate production |
| 03/12/2008 | CN101139361A Targeting osteoporosis-resistant drug and preparation method thereof |
| 03/12/2008 | CN101139360A Phosphamide organophosphorus compounds |
| 03/12/2008 | CN101139359A Steric isomer of chloramines phosphor, preparation and use thereof and composition using the isomer as active component |
| 03/12/2008 | CN101139358A Ethoxy combretastatin and preparation and use of its prodrug |
| 03/12/2008 | CN101139355A Blocked mercaptosilane coupling agents for filled rubbers |
| 03/12/2008 | CN100374452C Transition metal complex having diphosphine complex as ligand |
| 03/12/2008 | CN100374451C Method and device for producing amide continuously |
| 03/12/2008 | CN100374450C Triethyl phosphite producing process |
| 03/12/2008 | CN100374415C Fluorinated onium salts |
| 03/11/2008 | US7342124 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
| 03/11/2008 | US7342122 Platinum or Palladium as a metal; soft tissues surrounding bone and bone-related diseases: bone cancer and osteoporosis; chemotherapy; inhibition of DNA synthesis, growth arrest in G2 phase of the cell cycle and undergo apoptosis; cytostatic and/or cytotoxic agents |
| 03/11/2008 | US7342114 4-O esters such as thymin-1-yl alkyl ester; cancer; type II DNA topoisomerase inhibition, enzyme mediated production of lethal DNA strand breaks |